AbbVie Inc. Files 8-K Report
Ticker: ABBV · Form: 8-K · Filed: Feb 26, 2025 · CIK: 1551152
| Field | Detail |
|---|---|
| Company | Abbvie Inc. (ABBV) |
| Form Type | 8-K |
| Filed Date | Feb 26, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-filing, exhibits
Related Tickers: ABBV
TL;DR
ABBV filed an 8-K on Feb 26, 2025 - likely routine updates.
AI Summary
On February 26, 2025, AbbVie Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits." No specific financial transactions or material events were detailed in the provided excerpt, suggesting it may be a routine filing or related to exhibit updates.
Why It Matters
This filing indicates AbbVie Inc. is providing updates to the SEC, which could include new exhibits or other required disclosures relevant to investors monitoring the company's regulatory compliance.
Risk Assessment
Risk Level: low — The filing appears to be a standard 8-K for "Other Events" and exhibits, without immediate indication of significant new risks or material adverse information.
Key Players & Entities
- AbbVie Inc. (company) — Filer
- February 26, 2025 (date) — Date of earliest event reported
FAQ
What is the primary purpose of this 8-K filing for AbbVie Inc.?
The filing is for "Other Events" and "Financial Statements and Exhibits," indicating it pertains to updates or disclosures beyond typical material events.
When was this 8-K report filed by AbbVie Inc.?
The report was filed on February 26, 2025.
What is AbbVie Inc.'s Central Index Key (CIK)?
AbbVie Inc.'s CIK is 0001551152.
What is AbbVie Inc.'s Standard Industrial Classification (SIC) code?
AbbVie Inc.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Does this filing detail any specific new financial transactions or material events?
Based on the provided excerpt, no specific new financial transactions or material events are detailed; it appears to be a filing related to exhibits or other routine disclosures.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 26, 2025 regarding AbbVie Inc. (ABBV).